Intrinsic Value of S&P & Nasdaq Contact Us

Albemarle Corporation ALB NYSE

NYSE • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
38/100
1/7 Pass
SharesGrow Intrinsic Value
$315.83
+66.3%
Analyst Price Target
$185.93
-2.1%

Albemarle Corporation (ALB) generated $1.28B in operating cash flow for fiscal year 2025. After capital expenditures of $589.8M, free cash flow was $692.47M.

Free cash flow margin was 13.5% of revenue. Cash conversion ratio was -2.76x, suggesting some earnings are non-cash.

The company returned $190.53M in dividends to shareholders during the period.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (37/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was -2.76x suggests some earnings are non-cash items

Overall SharesGrow Score: 38/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
38/100
SG Score
View full scorecard →
VALUE
64/100
Price-to-Earnings & upside
→ Valuation
FUTURE
26/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
37/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Albemarle Corporation Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $1.28B$1.28B$702.07M$1.33B$1.91B
Capital Expenditure $-589.8M$-589.8M$-1.69B$-2.15B$-1.26B
Free Cash Flow $692.47M$692.47M$-983.72M$-823.96M$646.2M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message